News

Hosted on MSN1mon
ADA Advises Against Compounded GLP-1s; Growth Hormone Therapy Guide; T1D Outcomes Up
The American Diabetes Association (ADA) urged healthcare providers against prescribing non-FDA approved compounded GLP-1 and dual GIP/GIP-1 receptor agonists for type 2 diabetes or obesity and ...
Hosted on MSN10mon
New weight loss drugs are on the way — and the health benefits are even more promising
Pharmaceutical companies are racing to develop new weight loss drugs following the success of Ozempic and Wegovy — and this latest round of medications could come with more health benefits and ...